Navigation Links
Neurobiological Technologies Reports Third Quarter Financial Results
Date:5/12/2008

- Conference Call at 10:30 a.m. ET, May 13 -

EMERYVILLE, Calif., May 12 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII) today announced financial results for its fiscal third quarter and the nine months ended March 31, 2008.

Revenues for the three months ended March 31, 2008 were $3.7 million compared to $4.9 million for the same three months last year.

Research and development expenses were $5.9 million for the third quarter of 2008 compared to $7.7 million for the same quarter last year. General and administrative expenses were $1.8 million for the three months ended March 31, 2008 compared to $1.7 million in the same period last year.

The net loss for the third quarter of fiscal 2008 was $5.1 million, or $0.19 per share, compared with a net loss of $4.4 million, or $1.04 per share, for the third quarter of 2007.

Revenues for the first nine months of fiscal 2008 were $11.2 million compared to $13.7 million in the same period of 2007. Research and development expenses were $18.8 million for the nine months ended March 31, 2008 compared to $19.2 million for the same period of 2007. General and administrative expenses were $5.3 million for the nine months ended March 31 compared to expenses of $4.7 million for the same period in 2007. The net loss for the nine months ended March 31, 2008 was $12.9 million, or $0.76 per share, compared to a net loss of $9.9 million, or $2.35 per share, for the nine months ended March 31, 2007.

Cash, cash equivalents and short-term investments were $34.6 million at March 31, 2008, and long-term investments were $11.7 million, totaling $46.3 million. During the three months ended March 31, 2008, NTI wrote-down the value
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Neurobiological Technologies Sets Date for Third Quarter Financial Results
2. Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
3. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
4. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
5. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
6. Neurobiological Technologies Sets Date for Research and Development Day
7. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
8. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
9. Neurobiological Technologies Sets Date for Second Quarter Financial Results
10. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
11. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , "The interface is the device," Nobel laureate ... properties to be found at the junctures where ... world of nanotechnology, the interfaces between layers of ... in such high-tech favorites as spintronics, high-temperature superconductors, ...
(Date:1/15/2014)... Niagara Thermal Products is proud to announce that ... ("B3") as the critical thermal component supplier in support ... Corps of Engineers.  B3 has developed the only comprehensive ... destroys VOCs and other chemical pollutants, allergens and organic ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... conjugates for cancer, today announced the appointment of Thomas C ... has over 20 years, development experience gained in the biotechnology ... "I am delighted to welcome Tom at this ...
(Date:1/15/2014)... , January 15, 2014 A study ... races on the Formula 1 track could help to tackle ... Applied Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) ... healthcare provider Simplyhealth. Telemetry technology, which is inspired ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... partnership with Baxa Corporation, announces the, availability of ... laws and regulations related to sterile ... 30 Baxa Corporation announces,the availability of a ... for sterile compounding and USP ,compliance. The ...
... Inc., an innovative provider of advanced neuromodulation products designed to ... HealthSouth Corporation, the nation’s largest provider of inpatient rehabilitative healthcare ... Rehabilitation System and the NESS L300™ Foot Drop System to ... ...
... ALS CLINICALS AND DRUG DEVELOPMENT, ROCKVILLE, Md., ... CUR ) announced that Dr. Thomas Hazel ... Research. He will be,working with Dr. Karl Johe, ... company,s upcoming clinical trial for ALS,(Amytrophic Lateral Sclerosis, ...
Cached Biology Technology:CriticalPoint(TM) Introduces Crosswalk Tool for Sterile Compounding Regulatory Requirements 2CriticalPoint(TM) Introduces Crosswalk Tool for Sterile Compounding Regulatory Requirements 3 Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 2 Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 3Neuralstem Fills Key Product Development Position 2
(Date:7/10/2014)... 10, 2014) Consuming a whole fresh avocado with ... enhanced provitamin A carotenoid (alpha- and beta-carotene) absorption and ... vitamin A, according to new research (1) published ... , Vitamin A is involved in reproductive health ... and vision; and has antioxidant properties. Provitamin A carotenoids, ...
(Date:7/10/2014)... University Medical Center (CUMC) researchers have created a way ... pigmentosa (RP), a leading cause of vision loss. The ... induced pluripotent stem (iPS) cell technology to transform skin ... a patient-specific model for disease study and preclinical testing. ... Tsang, MD, PhD, showed that a form of RP ...
(Date:7/9/2014)... of protein, that,s not why the Millennials are eating it, ... Club Inc.,s annual International Recognition Days convention July 10th in ... want dishes that are quick, easy to cook and that ... care less about any health benefits of Tofu," said lead ... and because it,s quick to cook and it,s filling.", The ...
Breaking Biology News(10 mins):New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2Patient-specific stem cells and personalized gene therapy 2Patient-specific stem cells and personalized gene therapy 3
... the National Center for Supercomputing Applications was barely ... Connection Machines, CM-2, was just being installed, and ... University of Illinois, launched the Theoretical Biophysics Group ... analytical tools of physics and chemistry, coupled with ...
... Heidelberg, Germany, September 17th, 2009 / b3c newswire ... station PROcellcare based on a 96 well plate. ... licensing partner EMBL (European Molecular Biology Laboratory). ... live cells (in vitro) under the microscope with ...
... Researchers at the Department of Biochemistry and Molecular ... revealed the process by which proteins with a ... lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, ... carried out an analysis of their 3D structure ...
Cached Biology News:Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 2Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 3Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 4New Automatic cell feeding station PROcellcare for life cell imaging 2Mechanism related to the onset of various genetic diseases revealed 2Mechanism related to the onset of various genetic diseases revealed 3
... 26] to Presenilin 2 Alzheimer's disease ... the disease carry mutations in the presenilin ... protein (APP). These disease-linked mutations result in ... amyloid-beta (main component of amyloid deposits found ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
Biology Products: